AQR Capital Management
DNTH icon

AQR Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

AQR Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$346K Buy
+4,118
New +$238K ﹤0.01% 3339
2022
Q2 		– Sell
-2,206
Closed -$102K – 2204
2022
Q1 		$102K Buy
2,206
+689
+45% +$37.6K ﹤0.01% 2134
2021
Q4 		$107K Sell
1,517
-842
-36% -$84.6K ﹤0.01% 2143
2021
Q3 		$275K Buy
+2,359
New +$275K ﹤0.01% 2058
2021
Q1 		– Sell
-1,635
Closed -$205K – 2211
2020
Q4 		$205K Sell
1,635
-148
-8% -$16.8K ﹤0.01% 2086
2020
Q3 		$194K Sell
1,783
-8
-0.4% -$948 ﹤0.01% 2066
2020
Q2 		$215K Buy
1,791
+1,094
+157% +$154K ﹤0.01% 1977
2020
Q1 		$70K Buy
+697
New +$129K ﹤0.01% 1993

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management's DNTH Position: Q1 2026 in Review

AQR Capital Management opened a new position in Dianthus Therapeutics (DNTH) in Q1 2026: 4,118 shares worth $346K. The stake represents ﹤0.01% of the portfolio and ranks #3339 among its holdings. This is a return to the name: AQR Capital Management previously reported a position in DNTH as recently as Q1 2022.

AQR Capital Management first reported a position in DNTH in Q1 2020 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • AQR Capital Management held 4,118 shares of Dianthus Therapeutics worth $346K as of Q1 2026.
  • Dianthus Therapeutics was a new AQR Capital Management position in Q1 2026.
  • Dianthus Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3339 holding.
  • AQR Capital Management first reported a position in Dianthus Therapeutics in Q1 2020 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.